Get Involved

Registry (RaDaR)

RaDaR

 

 

Registry (RaDaR)

The National Registry of Rare Kidney Diseases (RaDaR) is an initiative by UK kidney specialists (the Renal Association). It is designed to pull together information from patients who have certain rare kidney diseases. This will give a much better understanding of how these illnesses affect people. It will also speed up research

 

For more information visit www.rarerenal.org or email f.yelnoorkar@nhs.net

Clinical Trials in Research for Children

Select a trial from the list below to find out more about what it’s all about and how you can get involved in helping others.

ARCI

This research study aims to find the relationship between the gene mutations associated with ARCI and the observable characteristics and traits of individuals affected by ARCI.

BOSS

The British Orthopaedic Surgery Surveillance (BOSS) Study is a nationwide reporting mechanism to determine the epidemiology and outcomes in rare orthopaedic diseases.

Eclipse

Should children and young people with long lasting seizures be treated with a medicine called phenytoin or levetiracetam in an emergency setting.

Ignite

A trial to assess the role of intravenous immunoglobulin in the management of children with encephalitis

Genetic Determinants of Kawasaki Disease

An investigation into Kawasaki Disease by looking at the variation of genes involved in the immune system.

HI-Light

The purpose of this study is to test the effectiveness of home-based light therapy using hand-held units and topical steroid for the treatment of vitiligo.

PREDNOS 2

To evaluate the effectiveness of a six day course of daily prednisoline therapy at the time of URTI in reducing the development of subsequent nephrotic syndrome relapse in children with relapsing SSNS.

Registry (RaDaR)

An initiative by UK kidney specialists to pull together information from patients who have certain rare kidney diseases.

Torpedo

This study has been designed to find out whether it is better to give patients with Cystic Fibrosis antibiotics orally or intravenously.


Latest news from PPI

View all